Equities

Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (USD)5.01
  • Today's Change0.01 / 0.20%
  • Shares traded76.45k
  • 1 Year change-33.47%
  • Beta1.7125
Data delayed at least 15 minutes, as of Dec 09 2019 15:38 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

  • Revenue in USD (TTM)82.49m
  • Net income in USD-114.84m
  • Incorporated2000
  • Employees401.00
  • Location
    Pacific Biosciences of California Inc1305 O'brien DriveMENLO PARK 94025United StatesUSA
  • Phone+1 (650) 521-8000
  • Fax+1 (302) 636-5454
  • Websitehttps://www.pacb.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Establishment Labs Holdings Inc81.71m-43.11m516.87m505.00--11.78--6.33-2.10-2.103.992.130.68171.604.06161,807.90-35.96---42.15--59.20---52.76--3.52-5.840.5235--76.49--39.54------
Cutera, Inc.175.39m-36.55m533.33m402.00--12.10--3.04-2.62-2.6212.423.101.522.677.21436,283.60-31.76-1.21-56.35-1.7550.2754.91-20.84-0.98351.05-70.390.0279--7.4116.88-182.51--23.54--
Viewray Inc91.98m-101.73m566.64m221.00--3.70--6.16-1.05-1.050.94511.090.34121.683.29416,181.00-37.74-63.61-46.06-109.53-1.031.56-110.60-180.492.49-31.840.3396--137.8391.31-9.63--16.76--
SurModics, Inc.100.08m7.59m569.87m369.0076.354.6438.245.690.55090.55097.269.070.61783.207.67271,211.404.694.605.655.1686.3784.897.597.893.81--0.000.0023.0411.74365.73-9.0624.26--
AngioDynamics, Inc.251.34m-11.95m579.72m750.00--0.953442.832.31-0.31851.626.6316.160.36312.146.91239,367.60-1.73-2.11-1.85-2.3159.5852.49-4.76-5.212.570.35610.00--3.43-5.2518.21---24.38--
Orthopediatrics Corp68.17m-10.82m587.31m80.00--6.82--8.62-0.7665-0.7634.835.750.5920.56945.77852,100.00-9.40---12.50--74.35---15.88--1.61-2.590.373--26.17--48.90------
AxoGen Inc101.98m-27.33m657.94m278.00--4.86--6.45-0.6999-0.69992.613.430.64581.476.93366,843.50-17.30-31.05-19.04-36.6482.2181.92-26.80-34.117.38--0.0004--38.9150.29-114.42--93.41--
Intersect ENT Inc110.17m-40.07m665.28m393.00--6.00--6.04-1.28-1.283.543.520.82231.497.97280,333.30-29.91-19.77-34.68-22.4581.0080.81-36.37-28.545.49--0.00--12.6443.33-40.08--35.28--
LeMaitre Vascular Inc115.45m19.35m698.30m457.0036.585.1528.466.050.9550.9555.706.780.73461.338.28252,628.0012.3112.0213.8013.5968.5769.7016.7613.843.49--0.0029.394.6610.3434.3747.751.0618.17
Axonics Modulation Technologies Inc4.37m-66.85m730.23m87.00--7.93--167.18-2.39-2.390.15653.220.05190.29597.4550,206.90-79.41---115.00--49.70---1,530.43--6.76--0.2155--451.83---79.85------
Pacific Biosciences of California82.49m-114.84m765.17m401.00--15.00--9.28-0.7579-0.75790.5440.33340.50143.1710.08205,703.20-69.81-53.12-89.48-68.7233.2143.43-139.22-88.181.22-44.220.2336---15.8822.78-11.25--15.32--
Antares Pharma Inc104.85m-588.00k798.18m165.00--17.97355.697.61-0.0033-0.00330.64510.27211.063.323.75635,430.30-0.5955-27.03-0.848-36.3956.0551.31-0.5608-42.652.46-3.230.4755--16.5825.2561.09---22.33--
Lantheus Holdings Inc344.26m34.51m802.23m488.0023.617.9316.812.330.86560.86568.612.580.83235.227.84705,454.908.345.909.686.9850.5746.8210.025.542.083.540.66020.003.623.896.39--32.07--
MiMedx Group Inc303.47m35.33m820.68m690.0024.395.7720.002.700.30380.30382.631.281.682.494.93439,808.7019.617.5524.929.2588.1987.4711.645.632.9573.830.000060.0030.8299.46-59.34--71.02--
Orthofix Medical Inc459.54m-31.35m882.44m954.00--2.85--1.92-1.66-1.6524.1716.230.99281.245.97481,697.10-6.771.31-8.241.6278.2377.91-6.821.261.77--0.06430.004.432.64-15.26---10.86--
Cryolife Inc274.32m1.38m936.09m1.10k707.483.3749.003.410.03530.04187.397.400.4721.965.52249,385.500.23871.370.25471.5066.2265.250.50562.433.151.290.444130.4938.5513.30-190.11--5.93--
Data as of Dec 09 2019. Currency figures normalised to Pacific Biosciences of California Inc's reporting currency: US Dollar USD

Institutional shareholders

37.10%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 201910.25m6.70%
The Vanguard Group, Inc.as of 30 Sep 20197.51m4.91%
Magnetar Financial LLCas of 30 Sep 20197.07m4.62%
CNH Partners LLCas of 30 Sep 20196.87m4.49%
Alpine Associates Management, Inc.as of 30 Sep 20195.50m3.60%
ARP Americas LPas of 30 Sep 20195.37m3.51%
Water Island Capital LLCas of 30 Sep 20194.59m3.00%
ArrowMark Colorado Holdings LLCas of 30 Sep 20193.46m2.26%
Goldman Sachs & Co. LLC (Private Banking)as of 30 Sep 20193.14m2.05%
SSgA Funds Management, Inc.as of 30 Sep 20192.98m1.95%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.